NCT03807947View on ClinicalTrials.gov

Radial Versus Femoral Access for Superselective Embolization of Hepatocellular Carcinoma

NAUnknownINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

January 31, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

April 30, 2020

Conditions
Hepatocellular CarcinomaHepatocellular Carcinoma Non-resectable
Interventions
PROCEDURE

Radial TAE - Bland embolization with 40-100 Microparticles

TAE - Bland embolization with 40-100 Microparticles performed via left transradial access

PROCEDURE

Transfemoral TAE - Bland embolization with 40-100 Microparticles

TAE - Bland embolization with 40-100 Microparticles performed via right transfemoral access

Trial Locations (1)

20089

Humanitas Research Hospital, Rozzano

Sponsors
All Listed Sponsors
lead

Humanitas Clinical and Research Center

OTHER